Literature DB >> 25589074

Monitoring and cell-specific deletion of C5aR1 using a novel floxed GFP-C5aR1 reporter knock-in mouse.

Christian M Karsten1, Yves Laumonnier1, Benjamin Eurich1, Fanny Ender1, Katharina Bröker1, Sreeja Roy1, Anna Czabanska1, Tillman Vollbrandt2, Julia Figge1, Jörg Köhl3.   

Abstract

Many of the biological properties of C5a are mediated through activation of its receptor (C5aR1), the expression of which has been demonstrated convincingly on myeloid cells, such as neutrophils, monocytes, and macrophages. In contrast, conflicting results exist regarding C5aR1 expression in dendritic cells (DCs) and lymphoid lineage cells. In this article, we report the generation of a floxed GFP-C5aR1 reporter knock-in mouse. Using this mouse strain, we confirmed strong C5aR1 expression in neutrophils from bone marrow, blood, lung, and spleen, as well as in peritoneal macrophages. Further, we show C5aR1 expression in lung eosinophils, lung- and lamina propria-resident and alveolar macrophages, bone marrow-derived DCs, and lung-resident CD11b(+) and monocyte-derived DCs, whereas intestinal and pulmonary CD103(+) DCs stained negative. Also, some splenic NKT cells expressed GFP, whereas naive NK cells and B2 cells lacked GFP expression. Finally, we did not observe any C5aR1 expression in naive or activated CD4(+) Th cells in vitro or in vivo. Mating the floxed GFP-C5aR1 mouse strain with LysMCre mice, we were able to specifically delete C5aR1 in neutrophils and macrophages, whereas C5aR1 expression was retained in DCs. In summary, our findings suggest that C5aR1 expression in mice is largely restricted to cells of the myeloid lineage. The novel floxed C5aR1 reporter knock-in mouse will prove useful to track C5aR1 expression in experimental models of acute and chronic inflammation and to conditionally delete C5aR1 in immune cells.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25589074     DOI: 10.4049/jimmunol.1401401

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.

Authors:  Norman F Russkamp; Robert Ruemmler; Julian Roewe; Bethany B Moore; Peter A Ward; Markus Bosmann
Journal:  FASEB J       Date:  2015-05-21       Impact factor: 5.191

2.  Complement Receptor C5aR1 Plays an Evolutionarily Conserved Role in Successful Cardiac Regeneration.

Authors:  Niranjana Natarajan; Yamen Abbas; Donald M Bryant; Juan Manuel Gonzalez-Rosa; Michka Sharpe; Aysu Uygur; Lucas H Cocco-Delgado; Nhi Ngoc Ho; Norma P Gerard; Craig J Gerard; Calum A MacRae; Caroline E Burns; C Geoffrey Burns; Jessica L Whited; Richard T Lee
Journal:  Circulation       Date:  2018-01-18       Impact factor: 29.690

Review 3.  Complement-Mediated Regulation of Metabolism and Basic Cellular Processes.

Authors:  Christoph Hess; Claudia Kemper
Journal:  Immunity       Date:  2016-08-16       Impact factor: 31.745

4.  The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1.

Authors:  Maciej M Markiewski; Surya Kumari Vadrevu; Sharad K Sharma; Navin Kumar Chintala; Shanawaz Ghouse; Jun-Hung Cho; David P Fairlie; Yvonne Paterson; Aristotelis Astrinidis; Magdalena Karbowniczek
Journal:  J Immunol       Date:  2017-02-22       Impact factor: 5.422

5.  Folic acid-mediated fibrosis is driven by C5a receptor 1-mediated activation of kidney myeloid cells.

Authors:  Ranjit K Sahu; Sandhya Xavier; Daniel Chauss; Luopin Wang; Claude Chew; Ronald Taylor; William B Stallcup; Jennie Z Ma; Majid Kazemian; Behdad Afzali; Jörg Köhl; Didier Portilla
Journal:  Am J Physiol Renal Physiol       Date:  2022-04-04

Review 6.  Complement-Mediated Events in Alzheimer's Disease: Mechanisms and Potential Therapeutic Targets.

Authors:  Andrea J Tenner
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

Review 7.  Complement in disease: a defence system turning offensive.

Authors:  Daniel Ricklin; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2016-05-23       Impact factor: 28.314

Review 8.  New insights into the immune functions of complement.

Authors:  Edimara S Reis; Dimitrios C Mastellos; George Hajishengallis; John D Lambris
Journal:  Nat Rev Immunol       Date:  2019-08       Impact factor: 53.106

9.  T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells.

Authors:  Giuseppina Arbore; Erin E West; Rosanne Spolski; Avril A B Robertson; Andreas Klos; Claudia Rheinheimer; Pavel Dutow; Trent M Woodruff; Zu Xi Yu; Luke A O'Neill; Rebecca C Coll; Alan Sher; Warren J Leonard; Jörg Köhl; Pete Monk; Matthew A Cooper; Matthew Arno; Behdad Afzali; Helen J Lachmann; Andrew P Cope; Katrin D Mayer-Barber; Claudia Kemper
Journal:  Science       Date:  2016-06-17       Impact factor: 47.728

Review 10.  Origin, Localization, and Immunoregulatory Properties of Pulmonary Phagocytes in Allergic Asthma.

Authors:  Franziska Hoffmann; Fanny Ender; Inken Schmudde; Ian P Lewkowich; Jörg Köhl; Peter König; Yves Laumonnier
Journal:  Front Immunol       Date:  2016-03-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.